BioLineRx Ltd. (BLRX)
USD 0.2
(-6.6%)
USD 0.2
(-6.6%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.8 Million | - | - | - | - | - |
| Cost of Revenue | 3.69 Million | 654 Thousand | 702 Thousand | 934 Thousand | 940 Thousand | 451 Thousand |
| Gross Profit | 1.1 Million | -654 Thousand | -702 Thousand | -934 Thousand | -940 Thousand | -451 Thousand |
| Operating Expenses | 50.8 Million | 29.15 Million | 24.77 Million | 22.92 Million | 28.11 Million | 25.6 Million |
| Selling, General and Administrative Expenses | 31.23 Million | 11.52 Million | 5.26 Million | 4.68 Million | 4.59 Million | 5.77 Million |
| Research and Development Expenses | 12.51 Million | 17.62 Million | 19.46 Million | 18.17 Million | 23.43 Million | 19.8 Million |
| Other Expenses | 7.05 Million | 5.67 Million | 42 Thousand | 70 Thousand | 78 Thousand | 27 Thousand |
| Cost and Expenses | 54.49 Million | 29.15 Million | 24.77 Million | 22.92 Million | 28.11 Million | 25.6 Million |
| Operating Income | -49.69 Million | -29.15 Million | -24.77 Million | -22.92 Million | -28.11 Million | -25.6 Million |
| Interest Expense | 2.16 Million | 2.15 Million | 984 Thousand | 1.47 Million | 1.82 Million | 21 Thousand |
| Income Tax Expense | 1000.00 | -6.07 Million | 1.09 Million | 911 Thousand | 1.36 Million | -4.45 Million |
| Earnings before Tax | -60.61 Million | -24.95 Million | -27.05 Million | -30.02 Million | -25.44 Million | -22.96 Million |
| Net Income | -60.61 Million | -18.87 Million | -28.14 Million | -30.93 Million | -26.8 Million | -18.5 Million |
| Earnings Per Share Basic | -0.94 | -0.37 | -0.64 | -1.84 | -2.75 | -2.56 |
| Earnings Per Share Diluted | -0.94 | -0.37 | -0.64 | -1.84 | -2.75 | -2.56 |
| Weighted Average Shares Outstanding | 64.22 Million | 51.59 Million | 44.19 Million | 16.85 Million | 9.76 Million | 7.23 Million |
| Weighted Average Shares Outstanding (Diluted) | 64.22 Million | 51.59 Million | 44.19 Million | 16.85 Million | 9.76 Million | 7.23 Million |
| Gross Margin | 0.23 | - | - | - | - | - |
| EBIT Margin | -11.89 | - | - | - | - | - |
| Profit Margin | -12.63 | - | - | - | - | - |
| EBITDA | -57.06 Million | -28.5 Million | -25.34 Million | -21.99 Million | -27.17 Million | -25.15 Million |
| Earnings Before Tax Margin | -10.35 | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 5.39 Million | 6.85 Million | 4.8 Million | 4.8 Million | - | - |
| Cost of Revenue | 1.14 Million | 1.45 Million | 3.69 Million | 4.62 Million | 221 Thousand | 198 Thousand |
| Gross Profit | 4.25 Million | 5.4 Million | 1.1 Million | 174 Thousand | -221 Thousand | -198 Thousand |
| Operating Expenses | 10.02 Million | 10.22 Million | 12.97 Million | 43.16 Million | 12.35 Million | 9.91 Million |
| Selling, General and Administrative Expenses | 7.79 Million | 7.72 Million | 9.86 Million | - | 9.63 Million | 6.9 Million |
| Research and Development Expenses | 2.22 Million | 2.49 Million | 3.1 Million | - | 2.72 Million | 3 Million |
| Other Expenses | 7.8 Million | 4.49 Million | 14.02 Million | 235 Thousand | -3.14 Million | -7.73 Million |
| Cost and Expenses | 11.16 Million | 11.67 Million | 16.66 Million | 47.79 Million | 12.35 Million | 9.91 Million |
| Operating Income | -5.77 Million | -4.82 Million | -11.86 Million | -42.99 Million | -12.35 Million | -9.91 Million |
| Interest Expense | 2.08 Million | 929 Thousand | -957 Thousand | 2.14 Million | 837 Thousand | 1.33 Million |
| Income Tax Expense | - | 5.41 Million | 662.18 Thousand | 1.21 Million | -2.3 Million | -6.39 Million |
| Earnings before Tax | 484 Thousand | -696 Thousand | -13.88 Million | -60.61 Million | -16.02 Million | -18.54 Million |
| Net Income | 484 Thousand | -696 Thousand | -13.88 Million | -60.61 Million | -16.02 Million | -18.54 Million |
| Earnings Per Share Basic | 0.01 | -0.01 | -0.19 | - | -0.26 | -0.30 |
| Earnings Per Share Diluted | 0.01 | -0.01 | -0.19 | - | -0.26 | -0.30 |
| Weighted Average Shares Outstanding | 79.83 Million | 72.43 Million | 72.43 Million | 64.22 Million | 61.93 Million | 61.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 79.83 Million | 72.43 Million | 72.43 Million | 64.22 Million | 61.93 Million | 61.53 Million |
| Gross Margin | 0.79 | 0.79 | 0.23 | 0.04 | - | - |
| EBIT Margin | -0.94 | 0.16 | -2.32 | - | - | - |
| Profit Margin | 0.09 | -0.10 | -2.89 | -12.63 | - | - |
| EBITDA | -5.04 Million | 1.13 Million | -11.15 Million | - | -14.96 Million | -17.01 Million |
| Earnings Before Tax Margin | -1.07 | -0.70 | -2.47 | -8.96 | - | - |
CGGYY
SONACOMS
VSACW
0604
VTX
GETI-B